Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TRV GP V, LLC (CIK 1990717) reported $401.0M across 3 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: RAPP ($223.3M, 55.68%), SEPN ($149.4M, 37.25%), MAZE ($28.4M, 7.08%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RAPP | RAPPORT THERAPEUTICS, INC. | $223.3M | 55.68% | 7.1M | Hold |
| 2 | SEPN | SEPTERNA, INC. | $149.4M | 37.25% | 6.2M | Hold |
| 3 | MAZE | MAZE THERAPEUTICS, INC. | $28.4M | 7.08% | 950,800 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31